Again, we show that when comparing patients without and with liver disease (CFLD), we could see that reduction of CRP was less marked in the latter group, suggesting that, in subjects with liver disease, the inflammatory status could take longer to be reduced. The gene discussed is CRP; the disease is liver disorder.